The DSM-5 Tobacco Use Disorder is diagnosed when 2 or more of 11 criteria are met within 12 months: using more than intended, failed attempts to cut back, significant time spent, cravings, neglecting responsibilities, continued use despite social problems, giving up activities, hazardous use, continued use despite health harm, tolerance, and withdrawal. Practical signs include: lighting up within 30 minutes of waking, feeling anxious or unable to concentrate without nicotine, and going out of your way to use when you otherwise wouldn't. Approximately 70% of daily smokers meet criteria for Tobacco Use Disorder — and nicotine salt vapers often show even faster dependence development.
Tobacco Use Disorder is the DSM-5 diagnosis that covers nicotine addiction from any source — cigarettes, vapes, chew, snus, nicotine pouches, or pipes. Two or more of the following 11 criteria within 12 months constitutes a diagnosis.
"Just one more" becoming a full pack or empty pod. Using in larger amounts or over longer periods than originally planned — a classic signal that control has eroded.
Wanting to stop or reduce use, with unsuccessful efforts. Repeated failed quit attempts — "I keep trying to quit" — are a primary diagnostic signal of Tobacco Use Disorder.
Planning days around smoke breaks, stepping outside repeatedly at inconvenient times, or structuring activities around nicotine access. For vapers, reaching for the device dozens of times per hour without noticing.
A strong urge or compulsion to use nicotine. Intrusive thoughts about smoking or vaping, especially in places or moments associated with use. Feeling preoccupied or restless until you can get a hit.
Stepping out during important meetings for a smoke break, taking longer breaks than allowed, or being distracted and irritable at work when you can't use.
Continuing despite partner complaints, continued vaping around children, or smoking despite relationship conflict about it. Choosing nicotine over interpersonal harmony.
Avoiding places where you can't smoke or vape, cutting social events short to use, or choosing activities partly based on whether nicotine use is possible.
Smoking while driving, vaping around children or in enclosed spaces with others, using during pregnancy, or smoking in situations where it creates fire or health risk.
Continuing to smoke or vape despite a doctor's recommendation against it, despite a respiratory or cardiovascular diagnosis, or despite knowing the effects. Continuing anyway.
Needing noticeably more nicotine to achieve the same effect, or finding that the same amount produces much less effect than it used to. Tolerance develops rapidly — often within weeks of starting regular use.
Experiencing nicotine withdrawal when stopping: irritability, anxiety, difficulty concentrating, restlessness, depressed mood, increased appetite, and sleep disruption. Feeling noticeably "off" without nicotine that resolves quickly with use is the classic sign of physical dependence.
The FTND is the most widely used clinical tool for measuring physical nicotine dependence. Unlike the DSM-5 criteria, it focuses on the behavioral patterns of use — and one question is the strongest single predictor of dependence severity:
Higher FTND scores predict more intense withdrawal and greater benefit from NRT (patches, gum, lozenge) or prescription medications like varenicline (Chantix) or bupropion (Wellbutrin).
2+ items: DSM-5 Tobacco Use Disorder criteria likely met. 5+: moderate to severe dependence. NRT or medication (varenicline, bupropion) significantly improves quit rates at higher dependence levels.
Traditional cigarettes use freebase nicotine, which has a high pH that makes it harsh at high concentrations — naturally limiting how much nicotine could be inhaled comfortably. Modern vapes (especially JUUL-type devices and their successors) use nicotine salts, which lower the pH, allowing much higher nicotine concentrations to be inhaled smoothly without harshness.
Nicotine salts reach the bloodstream and brain approximately 2–3 times faster than freebase nicotine. The faster a substance reaches the brain's reward system, the more reinforcing and addictive it becomes. A typical nicotine salt pod delivers the nicotine equivalent of 20–40 cigarettes in a device small enough to hide in a closed fist.
This means many vapers — particularly those who started with pod-style devices rather than cigarettes — are operating at dependence levels that feel unlike anything previously available in a tobacco product. Withdrawal from these products can be as intense or more intense than cigarette withdrawal, with faster onset. The "it's just vaping" perception is clinically incorrect for nicotine salt users.
Most nicotine users believe smoking or vaping reduces anxiety. This is one of addiction's most effective deceptions. What actually happens: regular nicotine use chronically suppresses baseline dopamine and serotonin activity, keeping anxiety elevated between doses. A cigarette or vape restores these neurotransmitters temporarily — producing relief that feels like relaxation.
Never-smokers have measurably lower anxiety levels than regular smokers. The "calm" from a cigarette is simply the removal of the withdrawal state that the previous cigarette created. Quitting initially worsens anxiety because the brain's stress systems are temporarily dysregulated — but anxiety levels drop significantly and persistently after 4–8 weeks of abstinence.
If you vape or smoke "to calm down," that's not evidence that nicotine reduces anxiety — it's evidence of dependence. The relief you feel is withdrawal relief, not pharmacological anxiolysis. Understanding this distinction matters for quitting: you're not giving up something that helps you manage stress; you're removing the thing that requires you to manage it in the first place.
The 11 DSM-5 Tobacco Use Disorder criteria: using more than intended, failed quit attempts, significant time spent, cravings, neglecting responsibilities, continued use despite social problems, giving up activities, hazardous use, continuing despite health harm, tolerance, and withdrawal. Practical signs: first use within 30 minutes of waking, anxiety or inability to concentrate without nicotine, and reaching for a vape or cigarette automatically without deciding to.
A validated 6-question clinical scale measuring physical nicotine dependence. Scores 0–2 = low, 3–4 = moderate, 5–6 = high, 7–10 = very high. The single strongest predictor: how soon after waking you use (within 5 minutes = maximum 3 points). Higher scores predict more severe withdrawal and greater benefit from NRT or varenicline.
Nicotine salt vapes deliver nicotine to the brain faster and at higher concentrations than traditional cigarettes, producing stronger dopamine responses and more rapid tolerance. Many nicotine salt users develop dependence faster and experience more intense withdrawal than cigarette smokers, despite perceiving vaping as "lighter."
The clinical diagnosis for nicotine addiction from any source — cigarettes, vapes, chew, snus, or nicotine pouches. 2+ of 11 criteria in 12 months. Severity: mild (2–3), moderate (4–5), severe (6+). The most commonly met criteria are tolerance, withdrawal, using more than intended, and failed quit attempts.
Yes. Regular nicotine use suppresses baseline dopamine and serotonin, keeping anxiety elevated between doses. The "calm" from smoking or vaping is withdrawal relief — not pharmacological anxiety reduction. Never-smokers have measurably lower anxiety than regular smokers. Quitting anxiety normalizes within 4–8 weeks of abstinence.
Forge tracks your quit streak, helps you through withdrawal hour by hour, and shows you exactly what your lungs and brain are recovering each day you stay clean.
Download Forge Free →